Clinical Trial Update: Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study. [Phase 4]

View source ↗

Summary

Phase 4 long-term pediatric growth study for fluticasone furoate nasal spray (Veramyst) completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis Allergic Perennial

Drugs mentioned

• Veramyst (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: COMPLETED | Results posted: 2012-02-07